USANA Health Sciences, Inc. (NYSE:USNA – Get Free Report) Director Gilbert A. Fuller sold 675 shares of the company’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Gilbert A. Fuller also recently made the following trade(s):
- On Wednesday, August 7th, Gilbert A. Fuller sold 674 shares of USANA Health Sciences stock. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06.
USANA Health Sciences Stock Performance
Shares of USANA Health Sciences stock opened at $40.33 on Thursday. The company has a market cap of $768.37 million, a P/E ratio of 14.25, a PEG ratio of 1.29 and a beta of 0.89. USANA Health Sciences, Inc. has a one year low of $34.15 and a one year high of $54.81. The firm has a fifty day moving average of $37.53 and a two-hundred day moving average of $42.07.
Analysts Set New Price Targets
Several research firms recently commented on USNA. DA Davidson reduced their price target on shares of USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating for the company in a research report on Wednesday, October 23rd. StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th.
Check Out Our Latest Analysis on USANA Health Sciences
Hedge Funds Weigh In On USANA Health Sciences
A number of large investors have recently made changes to their positions in the stock. Pzena Investment Management LLC increased its holdings in shares of USANA Health Sciences by 24.4% in the 2nd quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock valued at $44,183,000 after purchasing an additional 191,289 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of USANA Health Sciences by 0.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 683,158 shares of the company’s stock valued at $30,907,000 after purchasing an additional 3,889 shares in the last quarter. Pacer Advisors Inc. increased its holdings in shares of USANA Health Sciences by 14.3% in the 2nd quarter. Pacer Advisors Inc. now owns 467,352 shares of the company’s stock valued at $21,143,000 after purchasing an additional 58,597 shares in the last quarter. American Century Companies Inc. increased its holdings in shares of USANA Health Sciences by 12.3% in the 2nd quarter. American Century Companies Inc. now owns 159,782 shares of the company’s stock valued at $7,229,000 after purchasing an additional 17,460 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its holdings in shares of USANA Health Sciences by 13.5% in the 3rd quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock valued at $4,702,000 after purchasing an additional 14,756 shares in the last quarter. Hedge funds and other institutional investors own 54.25% of the company’s stock.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Read More
- Five stocks we like better than USANA Health Sciences
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- What a Trump Win Looks Like for the Market Now and Into 2025
- Investing in Commodities: What Are They? How to Invest in Them
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.